IV Fluids and Post-ERCP Pancreatitis

Launched by UNIVERSITY OF CALGARY · Jan 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how different amounts of intravenous (IV) fluids given during and after a procedure called endoscopic retrograde cholangiopancreatography (ERCP) can affect the risk of developing post-ERCP pancreatitis (PEP), which is a painful inflammation of the pancreas. Researchers want to find out if giving a specific amount of fluids shortly before and after the procedure can help prevent this complication, especially for patients who are being treated as outpatients and will go home soon after the procedure.

To participate in this study, you need to be at least 18 years old and scheduled for an ERCP procedure. You also need to be able to understand and agree to take part in the study. If you have any medical reasons that would prevent you from having an ERCP, or if you can't provide consent, you won't be eligible. If you join the study, you can expect close monitoring of your health and the amount of fluids you receive during the procedure. This research aims to help doctors determine the best hydration strategy to protect patients from potential complications after ERCP.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject referred for ERCP, regardless of indication;
• • Subject age 18 years or older;
• • Subject able to give informed consent to involvement be included.
• Exclusion Criteria:
• • Subject has a standard contraindication to ERCP;
• • Subject or surrogate unable or unwilling to provide informed consent;
• • Subject age \< 18 years.